Newsroom

Expensive, lifesaving treatments could be drastically reduced if Canada followed the U.S. model and started screening for breast cancer at 40.

Combining biomedical finesse and nature-inspired engineering, a uOttawa-led team of scientists have created a jelly-like material that shows great potential for on-the-spot repair to a remarkable range of damaged organs and tissues in the human body.

The Canadian Pandemic Preparedness Hub (CP2H) has been awarded more than $115 million to boost Canada’s capacity to develop and manufacture life-saving biotherapeutics, including vaccines, gene therapies and cell therapies. CP2H is co-led by the University of Ottawa and McMaster University, in partnership with The Ottawa Hospital.

Researchers highlights need for immediate shift in public health policy as early detection is key to reducing breast cancer death and complications.

Dr. Milroy has been named an “Officer of the Order of the British Empire,” one of the most prestigious honours awarded in the United Kingdom.

Successful study highlights how integrated virtual care delivered primary care to rural and remote communities.

The study proposes a large-scale workflow to produce natural killer cells and extracellular vesicles for cancer research & therapeutics.

Mild winter and early thaw part of changing climate trend that allows tick populations to survive and flourish in eastern Canada

A research team lead by Dr. Marisa Azad at The Ottawa Hospital has treated the first patient in Canada with bacteriophage (phage) therapy for a chronic artificial joint infection. Phages are viruses that prey on bacteria.

The rigorous study led by Canada Research Chair Dr. Arezu Jahani-Asl could have big implications for similar X-linked disorders that hobble the formation of new brain cells.